To determine whether irisin and asprosin levels are related to the metabolic status of patients independent of previously recognized PCOS risk factors such as insulin resistance, obesity and dyslipidemia, we stratified patients based on the presence/absence of ATPIII metabolic syndromes risk factors(s), or BMI23. The gene discussed is FNDC5; the disease is metabolic syndrome.